Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Stromal Tumors | 7 | 2022 | 20 | 3.070 |
Why?
|
| Gastrointestinal Neoplasms | 5 | 2022 | 33 | 2.330 |
Why?
|
| Leiomyosarcoma | 2 | 2022 | 9 | 1.400 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2022 | 34 | 0.950 |
Why?
|
| Carcinogenesis | 3 | 2022 | 130 | 0.900 |
Why?
|
| Transcription Factors | 4 | 2022 | 1541 | 0.900 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2024 | 1 | 0.880 |
Why?
|
| Cell Proliferation | 3 | 2024 | 1000 | 0.860 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 40 | 0.840 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2024 | 58 | 0.830 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 59 | 0.740 |
Why?
|
| Uterus | 1 | 2020 | 42 | 0.650 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 272 | 0.600 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2009 | 77 | 0.590 |
Why?
|
| Transcriptome | 2 | 2022 | 396 | 0.560 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2017 | 1 | 0.530 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 512 | 0.530 |
Why?
|
| Amyloid beta-Peptides | 4 | 2007 | 312 | 0.530 |
Why?
|
| 14-3-3 Proteins | 1 | 2017 | 19 | 0.530 |
Why?
|
| Proteomics | 2 | 2009 | 294 | 0.520 |
Why?
|
| Proteins | 2 | 2022 | 760 | 0.520 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 783 | 0.500 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 64 | 0.500 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 143 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 532 | 0.430 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 1494 | 0.410 |
Why?
|
| Inflammation | 1 | 2020 | 1162 | 0.400 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 457 | 0.400 |
Why?
|
| Mice | 11 | 2024 | 10994 | 0.380 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 195 | 0.350 |
Why?
|
| Neprilysin | 2 | 2007 | 9 | 0.340 |
Why?
|
| Plaque, Amyloid | 2 | 2007 | 41 | 0.330 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2022 | 55 | 0.320 |
Why?
|
| Alzheimer Disease | 2 | 2007 | 749 | 0.320 |
Why?
|
| Gene Expression | 3 | 2022 | 851 | 0.310 |
Why?
|
| Captopril | 2 | 2007 | 8 | 0.300 |
Why?
|
| Humans | 21 | 2024 | 64272 | 0.300 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2007 | 45 | 0.290 |
Why?
|
| Animals | 13 | 2024 | 20955 | 0.290 |
Why?
|
| HEK293 Cells | 3 | 2019 | 626 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2024 | 16 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 141 | 0.200 |
Why?
|
| Cell Line | 4 | 2009 | 2057 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 283 | 0.190 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2022 | 15 | 0.190 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2022 | 23 | 0.190 |
Why?
|
| Heterografts | 1 | 2022 | 66 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 342 | 0.180 |
Why?
|
| Germinal Center | 1 | 2022 | 39 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 391 | 0.180 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 35 | 0.180 |
Why?
|
| Receptors, CCR | 1 | 2021 | 2 | 0.170 |
Why?
|
| Protein Domains | 2 | 2019 | 154 | 0.170 |
Why?
|
| Benzodiazepines | 1 | 2021 | 102 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 162 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 116 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 180 | 0.170 |
Why?
|
| Immunoconjugates | 1 | 2021 | 93 | 0.160 |
Why?
|
| Genetic Therapy | 1 | 2007 | 799 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 460 | 0.160 |
Why?
|
| Succinate Dehydrogenase | 1 | 2019 | 15 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 202 | 0.150 |
Why?
|
| Substrate Specificity | 3 | 2009 | 340 | 0.150 |
Why?
|
| Female | 5 | 2024 | 33383 | 0.150 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 67 | 0.150 |
Why?
|
| Oncogenes | 1 | 2019 | 70 | 0.150 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 34 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 22 | 0.150 |
Why?
|
| Sarcoma, Synovial | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 47 | 0.150 |
Why?
|
| Triazoles | 1 | 2019 | 62 | 0.140 |
Why?
|
| Survival Rate | 1 | 2021 | 859 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 18 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2019 | 280 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2008 | 206 | 0.140 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 249 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 189 | 0.130 |
Why?
|
| Proteolysis | 1 | 2018 | 149 | 0.130 |
Why?
|
| Chromatin | 1 | 2022 | 616 | 0.130 |
Why?
|
| Cricetinae | 3 | 2007 | 368 | 0.130 |
Why?
|
| Taxoids | 1 | 2017 | 26 | 0.130 |
Why?
|
| Mutation | 3 | 2019 | 2633 | 0.130 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 41 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 91 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 785 | 0.130 |
Why?
|
| Deoxycytidine | 1 | 2017 | 43 | 0.130 |
Why?
|
| Disease Progression | 2 | 2018 | 1174 | 0.130 |
Why?
|
| Prognosis | 1 | 2021 | 1769 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 458 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 667 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 2482 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 901 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 1297 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2237 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2177 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1095 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1393 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 1597 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1999 | 0.080 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 24 | 0.080 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 52 | 0.080 |
Why?
|
| CHO Cells | 2 | 2007 | 189 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 3449 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 302 | 0.070 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 16 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 128 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 183 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 129 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 77 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 147 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 386 | 0.070 |
Why?
|
| Transplants | 1 | 2007 | 9 | 0.070 |
Why?
|
| Gliosis | 1 | 2007 | 28 | 0.070 |
Why?
|
| Cricetulus | 1 | 2007 | 100 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2008 | 542 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 85 | 0.060 |
Why?
|
| Triglycerides | 1 | 2008 | 244 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 76 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 33 | 0.060 |
Why?
|
| Transfection | 1 | 2007 | 696 | 0.060 |
Why?
|
| Insulysin | 1 | 2005 | 3 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 181 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 164 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2017 | 6741 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2005 | 130 | 0.050 |
Why?
|
| Adult | 2 | 2021 | 17136 | 0.050 |
Why?
|
| Middle Aged | 2 | 2021 | 17923 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 908 | 0.050 |
Why?
|
| Hyperkinesis | 1 | 2003 | 5 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2003 | 11 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 914 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Insecticides | 1 | 2003 | 45 | 0.050 |
Why?
|
| Insulin | 1 | 2005 | 686 | 0.040 |
Why?
|
| Haplorhini | 1 | 2021 | 14 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2007 | 887 | 0.040 |
Why?
|
| Japan | 1 | 2021 | 60 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 373 | 0.040 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 7 | 0.040 |
Why?
|
| Brain | 2 | 2005 | 1581 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 430 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 572 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 429 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 756 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 294 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1552 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 2005 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 364 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 884 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1619 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5528 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4782 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6306 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7923 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14663 | 0.010 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2005 | 2 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 51 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 146 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 141 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 196 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2005 | 205 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 201 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 181 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 28 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 766 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 2003 | 15 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 77 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2003 | 51 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2003 | 32 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 150 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 84 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 1335 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 296 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 167 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 365 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 261 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 383 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 449 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 668 | 0.010 |
Why?
|
| Male | 1 | 2021 | 30322 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 1223 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 934 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1622 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 3725 | 0.010 |
Why?
|